Targeted therapy in lung cancer: IPASS and beyond, keeping abreast of the explosion of targeted therapies for lung cancer

Benjamin Solomon , Peter Savas , Brett Hughes
Journal of Thoracic Disease 5 ( 5)

86
2013
Lung cancer beyond 2013: Many different diseases

Nick Pavlakis , Benjamin Solomon
Cancer Forum 37 ( 2) 143

2013
Adjuvant chemotherapy for resected non-small-cell lung cancer.

Paul A. Bunn , Benjamin Solomon , John D. Mitchell
Oncology 19 ( 13) 1685 -1697

6
2005
Management of a superior sulcus (pancoast) tumor.

Karen L. Kelly , Benjamin Solomon
Oncology 19 ( 11) 1515 -1520

2005
Molecular insights influencing the management of head and neck cancers

Danny Rischin , Benjamin Solomon , Annette Lim
Cancer Forum 39 ( 1) 29

1
2015
Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy.

Renata Kokanovic , Mary Duffy , Benjamin Solomon , Benjamin Solomon
Journal of Cancer Survivorship 15 ( 3) 392 -397

11
2021
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

Alice T. Shaw , Beow Y. Yeap , Mari Mino-Kenudson , Subba R. Digumarthy
Journal of Clinical Oncology 27 ( 26) 4247 -4253

2,230
2009
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma

Clare E. Weeden , Aliaksei Z. Holik , Richard J. Young , Stephen B. Ma
Molecular Cancer Therapeutics 16 ( 8) 1610 -1622

15
2017
Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.

Laird B Cameron , Damian H S Jiang , Kate Moodie , Catherine Mitchell
Cancer Imaging 17 ( 1) 7

10
2017
Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma.

Richard J. Young , Danny Rischin , Richard Fisher , Grant A. McArthur
Cancer Epidemiology, Biomarkers & Prevention 20 ( 6) 1230 -1237

78
2011
Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.

June Corry , Mathias Bressel , Tsien Fua , Alan Herschtal
International Journal of Radiation Oncology Biology Physics 98 ( 4) 948 -954

3
2017
Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

Benjamin Solomon , Richard J. Young , Mathias Bressel , Damien Urban
Cancer immunology research 6 ( 3) 295 -304

50
2018
New Treatment Options for ALK-Rearranged Non-Small Cell Lung Cancer.

Laird Cameron , Benjamin Solomon
Current Treatment Options in Oncology 16 ( 10) 49 -49

24
2015
Assessment of post-mortem-induced changes to the mouse brain proteome.

Stephen W. Hunsucker , Benjamin Solomon , Jeremy Gawryluk , Jonathan D. Geiger
Journal of Neurochemistry 105 ( 3) 725 -737

29
2008
Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent.

Benjamin Solomon , Paul A Bunn Jr
Future Oncology 1 ( 6) 733 -746

20
2005
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum.

Jennifer A. Westwood , William K. Murray , Melanie Trivett , Nicole M. Haynes
Journal of Immunotherapy 32 ( 3) 292 -301

41
2009
Navigating Through New, First-Line Treatment Options for Lung Cancer

Benjamin Solomon ,
Journal of Oncology Practice 14 ( 9) 539 -540

2018
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance.

Robert Weinkove , Zoe K McQuilten , Jonathan Adler , Meera R Agar
The Medical Journal of Australia 212 ( 10) 481 -489

146
2020